Increased Cardiovascular Risk?

The Women’s Health Initiative Study states that women who go on estrogen therapy have an increased risk of cardiovascular disease.  This is misleading.  A further look at the data is needed.  It was found that only women who were past menopause, or who had been off of estrogen for more than one year, had an increased risk.  This temporary risk increase only lasted for about one year.  After that, the risk of cardiovascular disease went down.  Estrogen is cardio-protective.  If used continuously, it reduces the risk of heart disease and stroke.

Reduction in Cardiovascular Disease

When Testosterone and Estrogen are given together in pellet form, we see improvements in arterial elasticity, diastolic function, and arterial constriction.  These hormones reduce the inflammation in the artery walls, leading to fewer heart attacks and strokes.  We also see a better balanced autonomic nervous system (The system that regulates our organs, and gives us our flight or fight response.)  This balance also reduces cardiovascular risk.

In most cases, Bio-Identical Hormone Replacement Therapy reduces cardiovascular risk.  However we can also provide other treatments, in addition to hormone therapy, to protect patients who might have a short-term increased risk.